Quarterly ResultMay 7, 2026, 07:52 AM
Viatris Q1 Revenue $3.5B, Net Earnings $176M; Reaffirms 2026 Guidance
AI Summary
Viatris Inc. reported strong first-quarter 2026 financial results, with total revenues reaching $3.5 billion, an 8% reported increase year-over-year, and U.S. GAAP net earnings of $176 million. The company also achieved $1.0 billion in Adjusted EBITDA, up 10% operationally. Viatris reaffirmed its full-year 2026 financial guidance and highlighted progress in key product launches and pipeline milestones, including the launch of Effexor® in Japan.
Key Highlights
- Total revenues for Q1 2026 were $3.5 billion, up 8% reported and 3% operationally year-over-year.
- U.S. GAAP net earnings were $176 million, significantly up from a $3.0 billion loss in Q1 2025.
- Adjusted EBITDA reached $1.0 billion, a 14% reported and 10% operational increase from Q1 2025.
- Adjusted EPS was $0.59, an 18% reported and 14% operational increase year-over-year.
- Greater China net sales grew 22% reported and 18% constant currency to $680.1 million.
- Brands net sales increased 10% reported and 4% constant currency to $2,332.5 million.
- Viatris reaffirmed its 2026 financial guidance, expecting total revenues of $14.45B-$14.95B.
- The company expects over $2.5 billion of cash available for deployment in 2026.